Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Elsa Kalbacher Mansoor Raza Mirza Esther Drill Peter Vuylsteke Felix Hilpert Anneke Westermann Josep M. del Campo David M. O'Malley Cristina Churruca Nicoletta Colombo Martin K Oehler John Farley David Cibula Sandro Pignata Ignace Vergote Ignacio Romero Jalid Sehouli Robert L Coleman Regina Berger Carol Aghajanian Gopa Iyer Susana Banerjee Andrew R Clamp Kathleen N. Moore Rachel N. Grisham Christian Marth Bradley J. Monk Amit M. Oza Gunnar B. Kristensen Isabelle Ray-Coquard |
| Publication date | September 16, 2024 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |